How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Tyvaso DPI cost savings if eligible
The Tyvaso DPI patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Tyvaso DPI, regardless of the retail price.
Am I eligible for the Tyvaso DPI patient assistance program?
To find out if you are eligible for Tyvaso DPI assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Tyvaso DPI patient assistance program?
Our application process aims to make it as easy as possible to apply for the Tyvaso DPI patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Tyvaso DPI.
NiceRx will review your application and determine whether you may be eligible for Tyvaso DPI assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Tyvaso DPI patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period, we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Tyvaso DPI.
Is NiceRx a Tyvaso DPI coupon provider?
NiceRx is a service provider that helps eligible individuals access the Tyvaso DPI patient assistance program. We do not offer trial offers or free Tyvaso DPI samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Tyvaso DPI coupons, discount cards, or Tyvaso DPI copay cards.
Can NiceRx help me get Tyvaso DPI cheaper if I have insurance?
NiceRx may be able to help you if your insurance company will not pay for your Tyvaso DPI medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.
How much does Tyvaso DPI cost without insurance?
Tyvaso DPI prices without insurance will vary depending on how much you buy. Prices will also vary by retailer. As a guide, Tyvaso inhalation solution (0.6 mg/mL) typically costs $2,900 for 11.6 milliliters.
How much does Tyvaso DPI cost with insurance?
The copay for Tyvaso DPI will vary by the terms of your healthcare plan. To find out what you might need to pay for Tyvaso DPI with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.
What is Tyvaso DPI?
Tyvaso DPI (dry powder inhaler) is an FDA (U.S. Food and Drug Administration) approved medication and a trademark of United Therapeutics Corporation. FDA approval of the new drug application for Tyvaso DPI is based on data from Breeze, an open-label study. Tyvaso DPI is a prostacyclin mimetic used to treat:
- Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies included patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH or PAH linked to connective tissue diseases.
- Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability. The study included patients with etiologies of idiopathic interstitial pneumonia inclusive of idiopathic pulmonary fibrosis, combined pulmonary fibrosis, and emphysema, and WHO Group 3 connective tissue disease
PAH is a condition in which the narrowing of the arteries connecting the heart to the lungs results in high blood pressure. PH-ILD refers to conditions caused by scarring (fibrosis) in the lungs, including idiopathic pulmonary fibrosis.
What doses of Tyvaso DPI are available?
Tyvaso DPI is available as a dry powder formulation, in the following doses: Single-dose plastic cartridges containing 16, 32, 48, or 64 mcg of treprostinil inhalation powder.
Please read the additional information for important safety information as well as prescribing information, and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Tyvaso DPI active ingredients
Tyvaso DPI contains treprostinil as the active ingredient.
Tyvaso DPI side effects
The most common side effects of Tyvaso DPI in clinical trials include:
- Throat irritation
- Pharyngolaryngeal pain
In rare instances, Tyvaso DPI can cause more serious side effects. These can include:
- Symptomatic hypotension
- Inhibition of platelet aggregation and increased risk of bleeding
- Bronchospasm – those with a history of hyperreactive airway disease may be more sensitive
Your doctor will assess the benefits of using Tyvaso DPI against your risk of adverse events. Patients are encouraged to report negative side effects or adverse reactions of Tyvaso DPI to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Tyvaso DPI drug interactions
Tyvaso DPI can interact with other medications.
- The cytochrome CYP2C8 enzyme inhibitor, gemfibrozil, increases exposure to treprostinil. The CYP2C8 enzyme inducer decreases exposure to treprostinil. It is unclear if the safety and efficacy of treprostinil by the inhalation route are altered by inhibitors or inducers of CYP2C8
- Acetaminophen, warfarin, and fluconazole did not show a clinically significant effect on the pharmacokinetics of treprostinil
This list is not exhaustive and other prescription drugs may interact with Tyvaso DPI.
Tyvaso DPI contraindications
You should not use Tyvaso DPI if you:
- Are allergic to the active ingredient treprostinil
- Are allergic to any of the other ingredients in Tyvaso DPI
Talk to your doctor before using Tyvaso DPI if you:
- Are taking any of the medications that could interact with Tyvaso DPI
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Tyvaso DPI generic
Tyvaso DPI is the trademark brand name for treprostinil manufactured by United Therapeutics Corporation. A generic version of treprostinil is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Tyvaso DPI savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.